Bank OZK Extends A $915M San Diego Lab Loan To Oct. 9
The 1.7M SF RaDD project finished in 2024 with no tenants; Citi calls the extension a forbearance.
CRE360 Editorial Desk·Oct 10, 2026
Topic archive
Life Sciences
CRE 360 Signal editorial tag
16 published items
Newsletters
The Best Bid For Empty Office Came From Retail
Burlington paid for a building that is 4% leased.
The Lease Term Was the Headline
A 78 million dollar Seattle-area drug plant came with 21 years of rent attached.
The Boom That Built Too Much
Life sciences was the consensus winner. Now three-quarters of last year's new lab space sits empty — and it's a clinic on supply discipline.
Signals
Greystar Lands Mass General Brigham As First Somerville Lab Tenant
A health system takes 105,000 sf in a 469,000 sf building two years after delivery.
CRE360 Editorial Desk·Oct 6, 2026
Life-Science Construction Fell From 25M SF to 5.6M, and 72% Is Pre-Leased
Cushman and Wakefield's Q2 pipeline shows a sector that has stopped building spec and started building for tenants.
CRE360 Editorial Desk·Sep 22, 2026
Bristol Myers Squibb Commits 2.3 Billion Dollars to a Houston Campus
A second pharma giant plants a Sun Belt flag, turning Generation Park into a life-sciences cluster.
CRE360 Editorial Desk·Aug 13, 2026
Longfellow Sells a Brand-New Lab Into a Cooling Market
A developer takes a freshly built spec lab off its balance sheet as U.S. lab leasing slows.
CRE360 Editorial Desk·Aug 10, 2026
The Biggest Lab Lease of the Quarter Landed in the Emptiest Lab Market
Lila Sciences takes 235,500 SF in Cambridge while Boston lab vacancy sits at 26%.
CRE360 Editorial Desk·Aug 3, 2026
Ackman Turns an Empty Manhattan Lab Into a $188M Bet on Brains
A mission buyer not a return fund sets the exit bid for stranded office-lab.
CRE360 Editorial Desk·Jul 30, 2026
Lab Demand Is Up 44% and Landlords Are Losing Anyway
Vacancy near 32% has cut lease terms by 30% — the recovery is arriving on tenants' paper.
CRE 360 Signal·Jul 20, 2026
Lab Space Just Posted Its Biggest Absorption Turn in a Decade
Vacancy is still ugly, but availability is falling and demand is surging.
CRE 360 Signal Editorial Desk·Jul 15, 2026
A Radiopharma Developer Takes a Full Building — and Onshores Manufacturing
AdvanCell's 128K SF Andover lease is a bet on U.S. drug production, not just lab space.
CRE 360 Signal Editorial Desk·Jul 6, 2026
Lab Space Just Hit Bottom — But Only the Best Buildings Get Saved
Availability is contracting for the first time in years, and the recovery is splitting by quality and metro.
CRE 360 Signal Editorial Desk·Jun 28, 2026
The Lab-Space Boom Just Failed Its First Leasing Test
Roughly three-quarters of 2025's new life sciences supply is still sitting empty.
CRE 360 Signal Editorial Desk·Jun 4, 2026
Zero Public Biotech Leases. That's the Story.
Alexandria's Q1 print broke the "life sciences bottoming" thesis in a single line on the earnings call.
CRE 360 Signal Editorial Desk·May 3, 2026